GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

Home・Aktien・BioArctic AB

B
BioArctic AB

Geschlossen

319.6 1.91

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

319

Max

320

Schlüsselkennzahlen
By Trading Economics
Einkommen	-208M -29M
Verkäufe	-259M 133M
KGV Branchendurchschnitt	28.665 76.798
EPS	-0.98
Gewinnspanne	-21.576
Angestellte	122
EBITDA	-206M -18M

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	2.8B 29B
Vorheriger Eröffnungskurs	317.69
Vorheriger Schlusskurs	319.6

BioArctic AB Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Dez. 2025, 17:29 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19. Dez. 2025, 16:47 UTC

Wichtige Markttreiber

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19. Dez. 2025, 16:10 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

21. Dez. 2025, 23:51 UTC

Market Talk

Oil Rises Amid Growing U.S.-Venezuela Tensions -- Market Talk

21. Dez. 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. Dez. 2025, 23:45 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

21. Dez. 2025, 23:35 UTC

Market Talk

Gold Edges Higher Amid Geopolitical Tensions -- Market Talk

19. Dez. 2025, 22:33 UTC

Ergebnisse

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19. Dez. 2025, 22:19 UTC

Ergebnisse

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19. Dez. 2025, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19. Dez. 2025, 21:44 UTC

Ergebnisse

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19. Dez. 2025, 21:38 UTC

Ergebnisse

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19. Dez. 2025, 21:00 UTC

Market Talk

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19. Dez. 2025, 20:23 UTC

Market Talk

Oil Futures End Down Week on Up Note -- Market Talk

19. Dez. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19. Dez. 2025, 18:38 UTC

Market Talk

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19. Dez. 2025, 18:00 UTC

Market Talk

Ergebnisse

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19. Dez. 2025, 17:41 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19. Dez. 2025, 17:24 UTC

Market Talk

Ergebnisse

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19. Dez. 2025, 17:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

19. Dez. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

19. Dez. 2025, 16:29 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19. Dez. 2025, 16:20 UTC

Akquisitionen, Fusionen, Übernahmen

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19. Dez. 2025, 16:19 UTC

Akquisitionen, Fusionen, Übernahmen

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19. Dez. 2025, 16:18 UTC

Akquisitionen, Fusionen, Übernahmen

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19. Dez. 2025, 16:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19. Dez. 2025, 16:16 UTC

Market Talk

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19. Dez. 2025, 16:05 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19. Dez. 2025, 16:04 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19. Dez. 2025, 15:37 UTC

Market Talk

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

Peer-Vergleich

Kursveränderung

BioArctic AB Prognose

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.